Nivolumab treatment followed by atezolizumab induced encephalitis and neuropathy with antiganglioside antibodies

Detalles Bibliográficos
Autores principales: Watanabe, Shohei, Yoshizumi, Kazuki, Moriguchi, Sayaka, Higashiyama, Tomoki, Negi, Yoshiki, Mikami, Koji, Kimura, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649576/
https://www.ncbi.nlm.nih.gov/pubmed/34926841
http://dx.doi.org/10.1016/j.ensci.2021.100386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649576/
https://www.ncbi.nlm.nih.gov/pubmed/34926841
http://dx.doi.org/10.1016/j.ensci.2021.100386

Ejemplares similares